Literature DB >> 11914975

Opioid receptor blockade eliminates mood effects of aerobic gymnastics.

A Järvekülg1, A Viru.   

Abstract

The contribution of opioid receptors to the mood effects of aerobic gymnastics was tested by oral administration of naltrexone (25 or 50 mg) in 12 healthy women (aged 22 - 30 years). The opioid receptor blockade eliminated decreased anxiety, negative affect level and depressiveness as well as increased positive affect level, as found in a placebo trial after a 50 min session of aerobic gymnastics. 50 mg of naltrexone was more effective than 25 mg. Administration of 50 mg of naltrexone without exercise did not cause any significant changes in anxiety, positive and negative affect levels or depressiveness.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11914975     DOI: 10.1055/s-2002-23168

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  9 in total

1.  Possible directions for the discovery of new antidepressant treatments.

Authors:  Simon N Young
Journal:  J Psychiatry Neurosci       Date:  2011-01       Impact factor: 6.186

2.  Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone.

Authors:  Charles P O'Brien; David R Gastfriend; Robert F Forman; Edward Schweizer; Helen M Pettinati
Journal:  Am J Addict       Date:  2010-12-28

3.  Nicotinic Receptors: Role in Addiction and Other Disorders of the Brain.

Authors:  Geeta Sharma; Sukumar Vijayaraghavan
Journal:  Subst Abuse       Date:  2008-11-11

4.  Anhedonia as a key clinical feature in the maintenance and treatment of opioid use disorder.

Authors:  Brian D Kiluk; Sarah W Yip; Elise E DeVito; Kathleen M Carroll; Mehmet Sofuoglu
Journal:  Clin Psychol Sci       Date:  2019-09-23

5.  Anhedonia to music and mu-opioids: Evidence from the administration of naltrexone.

Authors:  Adiel Mallik; Mona Lisa Chanda; Daniel J Levitin
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

6.  Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials.

Authors:  Ziad Saad; Derrek Hibar; Maggie Fedgchin; Vanina Popova; Maura L Furey; Jaskaran B Singh; Hartmuth Kolb; Wayne C Drevets; Guang Chen
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-03       Impact factor: 5.176

7.  Advocating neuroimaging studies of transmitter release in human physical exercise challenges studies.

Authors:  Henning Boecker; Ahmed Othman; Sarah Mueckter; Lukas Scheef; Max Pensel; Marcel Daamen; Jakob Jankowski; Hh Schild; Tr Tölle; M Schreckenberger
Journal:  Open Access J Sports Med       Date:  2010-09-06

Review 8.  The Effects of Acute Exercise on Mood, Cognition, Neurophysiology, and Neurochemical Pathways: A Review.

Authors:  Julia C Basso; Wendy A Suzuki
Journal:  Brain Plast       Date:  2017-03-28

9.  The impact of depression and anxiety treatment on biological aging and metabolic stress: study protocol of the MOod treatment with antidepressants or running (MOTAR) study.

Authors:  Bianca A Lever-van Milligen; Josine E Verhoeven; Lianne Schmaal; Laura S van Velzen; Dóra Révész; Catherine N Black; Laura K M Han; Melany Horsfall; Neeltje M Batelaan; Anton J L M van Balkom; Digna J F van Schaik; Patricia van Oppen; Brenda W J H Penninx
Journal:  BMC Psychiatry       Date:  2019-12-30       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.